Sales of Johnson & Johnson's medical devices and diagnostics by franchise 2018-2020

Johnson & Johnson’s medical devices and diagnostics segment earned about 8.2 billion U.S. dollars through its surgery franchise specifically, in 2020. The orthopedics franchise was the segment’s second-largest field, generating roughly 7.8 billion U.S. dollars that year.

J&J’s revenue

In 2020, Johnson & Johnson’s global revenue amounted to some 82.6 billion U.S. dollars, which was an increase of almost ten billion U.S. dollars compared to two years earlier. J&J has three major divisions: pharmaceutical, medical devices and diagnostics, and consumer. In 2020, an estimated 23 billion U.S. dollars were generated through the medical devices and diagnostics division. Roughly 17 percent of the company’s global revenue was generated through consumer health. Over the years, the multinational company with its various segments generated roughly half of its revenue in the United States, making it the company’s main market. In 2020, roughly 19 billion U.S. dollars were generated in Europe, the company’s second most yielding region.